Premium
Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22 ‐positive B‐cell acute lymphoblastic leukaemia
Author(s) -
Calvo Charlotte,
CabannesHamy Aurélie,
Adjaoud Dalila,
Bruno Bénédicte,
Blanc Laurence,
Boissel Nicolas,
Tabone MarieDominique,
WillsonPlat Geneviève,
Villemonteix Juliette,
Baruchel André,
Brethon Benoit
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16732
Subject(s) - medicine , tolerability , minimal residual disease , salvage therapy , refractory (planetary science) , gastroenterology , adverse effect , transplantation , calicheamicin , chemotherapy , oncology , bone marrow , surgery , astrobiology , physics , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom